AU7513291A - Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use - Google Patents

Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use

Info

Publication number
AU7513291A
AU7513291A AU75132/91A AU7513291A AU7513291A AU 7513291 A AU7513291 A AU 7513291A AU 75132/91 A AU75132/91 A AU 75132/91A AU 7513291 A AU7513291 A AU 7513291A AU 7513291 A AU7513291 A AU 7513291A
Authority
AU
Australia
Prior art keywords
hexetidine
salts
preparation
pharmaceutical composition
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU75132/91A
Other versions
AU643772B2 (en
Inventor
Andre Salkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7513291A publication Critical patent/AU7513291A/en
Application granted granted Critical
Publication of AU643772B2 publication Critical patent/AU643772B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of hexetidine or its non-toxic derivatives or salts, with the use envisaged for the preparation of a pharmaceutical composition having ophthalmic antiseptic activity, making possible, in particular, the therapeutic treatment of connective tissues in the absence or presence of ophthalmic prostheses, and in particular contact lenses. Application: ophthalmology.
AU75132/91A 1990-04-18 1991-04-17 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use Ceased AU643772B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR909004945A FR2661091B1 (en) 1990-04-18 1990-04-18 USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE.
FR9004945 1990-04-18

Publications (2)

Publication Number Publication Date
AU7513291A true AU7513291A (en) 1991-10-24
AU643772B2 AU643772B2 (en) 1993-11-25

Family

ID=9395848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75132/91A Ceased AU643772B2 (en) 1990-04-18 1991-04-17 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use

Country Status (12)

Country Link
EP (1) EP0453337B1 (en)
JP (1) JPH04234818A (en)
AT (1) ATE158719T1 (en)
AU (1) AU643772B2 (en)
BR (1) BR9101544A (en)
CA (1) CA2039566A1 (en)
DE (1) DE69127767T2 (en)
DK (1) DK0453337T3 (en)
ES (1) ES2109937T3 (en)
FR (1) FR2661091B1 (en)
HU (1) HUT57985A (en)
MC (1) MC2217A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009283A1 (en) * 1990-11-26 1992-06-11 Warner-Lambert Company Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same
DE10147186A1 (en) * 2001-09-25 2003-04-24 Beiersdorf Ag Synergistic antimicrobial composition, useful e.g. as cosmetic preservative and for treating skin disorders, comprises polyhexamethylene biguanide and distearyldimethylammonium chloride
US9737609B2 (en) * 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL89993C (en) * 1954-08-02
FR2552305B1 (en) * 1983-09-22 1985-12-20 Salkin Andre HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE
EP0215136B1 (en) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
US4666517A (en) * 1986-06-04 1987-05-19 Colgate-Palmolive Co. Antiplaque oral composition

Also Published As

Publication number Publication date
HU911272D0 (en) 1991-10-28
ES2109937T3 (en) 1998-02-01
EP0453337A2 (en) 1991-10-23
HUT57985A (en) 1992-01-28
MC2217A1 (en) 1993-02-02
EP0453337A3 (en) 1992-11-25
CA2039566A1 (en) 1991-10-19
JPH04234818A (en) 1992-08-24
EP0453337B1 (en) 1997-10-01
DE69127767D1 (en) 1997-11-06
FR2661091A1 (en) 1991-10-25
DE69127767T2 (en) 1998-04-30
DK0453337T3 (en) 1998-05-18
AU643772B2 (en) 1993-11-25
BR9101544A (en) 1991-12-10
ATE158719T1 (en) 1997-10-15
FR2661091B1 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
AU7182296A (en) Terfenadine metabolites and their optically pure isomers for treating allergic disorders
EE02971B1 (en) Use of droloxyfene or its salts in the manufacture of a medicament for the treatment of bone diseases
PT88985A (en) Process for the preparation of nasal and ophthalmic pharmaceutical compositions containing azelastine
IE811654L (en) Ophthalmic composition
NO975962D0 (en) Drug preparation comprising albumin as active ingredient
GR3006815T3 (en)
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
EP0403360A3 (en) Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
AU1458495A (en) Application of riluzole in the treatment of mitochondrial diseases
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
DK0410749T3 (en) Anthocyanidins for the treatment of ophthalmic diseases
DE3273950D1 (en) Use of 1-(p-isopropoxyethoxymethyl-phenoxy)-3-isopropylaminopropan-2-ol for the preparation of a medicament for the reduction of internal pressure in the eye
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
AU2129200A (en) Use of nerve growth factor for therapy of intraocular tissue pathologies
AU1217392A (en) Corneal treatment agents
AU1706392A (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
PT97878A (en) Process for the preparation of a pharmaceutical composition for ophthalmic use containing hexetidine or derivatives or salts thereof
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
GR3018349T3 (en) Use of naproxen as mydriatic agent.
BG96092A (en) THIENOTHIOPYRAN SULFONAMIDE DERIVATIVES AND THEIR APPLICATION IN OPHTHALMOLOGICAL PREPARATIONS
RU93021719A (en) METHOD OF TREATMENT OF THE RETINA
UA19587A (en) Method for surgical elimination of traumatic iridodialysis in patients with post-traumatic corneal caligo